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An infant with neonatal adrenoleukodystrophy ex- 
perienced extreme hypotonia and virtually continuous 
convulsions at four months of age and died. Light and 
electron microscopic examination revealed evidence of 
myopathy and the presence of mitochondrial in- 
clusions. Concentrations of very long-chain fatty acids 
were elevated in blood and fibroblasts and the 
oxidation of 14C-labeled fatty acids was defective. 
Urinary pipecolic add content was increased. Activity of 
the peroxisomal dihydroxyacetone phosphate 
acyltransferase, which catalyzes the first step in 
plasmalogen synthesis, was decreased. 
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Introduction 
Neonatal adrenoleukodystrophy is an autosomal 
recessive disorder characterized by profound hypotonia 
and intractable seizures [1]. Hypotonia is severe enough 
to suggest a diagnosis of primary myopathy. However, 
histologic studies of muscle have not been reported 
previously. These patients, as well as those with 
adrenoleukodystrophy, accumulate very long-chain 
fatty acids [1-4]. Classic adrenoleukodystrophy is X- 
linked; neonatal adrenoleukodystrophy is not. 
Although biochemical data was published on 11 
patients with neonatal adrenoleukodystrophy, clinical 
details are available on only 6 patients [5-8]. 
Hepatomegaly may be present and transaminase levels 
usually are abnormal. Histologic study demonstrates 
hepatic fibrosis [1]. Usually there is no clinical evidence 
of adrenal insufficiency; however, the adrenals have 
been very small at autopsy [1,8] and histologic 
examination has revealed extensive cortical atrophy and 
ballooned cells with ultramicroscopic evidence of 
lamellar lipid inclusions. The neuropathology was 
characterized by polymicrogyria as well as extensive 
demyelination in the cerebral white matter. 
Accumulation of very long-chain fatty acids in 
plasma and cultured fibroblasts is the diagnostic feature 
of classic X-linked adrenoleukodystrophy [9,10]. The 
levels obtained in neonatal adrenoleukodystrophy were 
very high [3,4], and elevated concentrations of these 
fatty acids also were found in the cerebrohepatorenal 
syndrome of Zellweger and in hyperpipecolic acid- 
emia [4]. 
We describe an infant with neonatal 
adrenoleukodystrophy; however, the electron 
microscopic appearance of the mitochondria in the 
muscle suggested a myopathy. The concentration of 
very long-chain fatty acids was relatively high, as were 
the ratios of C26:0 to C22:0 acids in plasma and 
fibroblasts. 
Case Report 
A 2-month-old infant (Fig 1) was transported from the neonatal 
intensive care unit of the AI-Hada Hospital in Saudi Arabia to the 
University of California San Diego Medical Center because of extreme 
hypotonia and convulsions. Her mother was a 37-year-old epileptic 
Saudi Arabian woman who had been treated with phenytoin for 16 
years and had received 100 mg twice-a-day during the pregnancy. 
Birth weight was 2,400 grams. Three older siblings were well. The 
fourth child, also a girl, had hypotonia and seizures. The elec- 
troencephalogram (EEG) was very abnormal and she was treated with 
phenobarbital and phenytoin. An extensive investigation in London, 
including muscle biopsy, did not yield a diagnosis. She died at 4 
months of age. There was no apparent consanguinity. 
The patient was meconium-stained at birth but none was evident 
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Figure 1. The patient photographed at 31/2 
illustrating the hypotonia and the ptosis on the left. 
months of  age, 
below the cords. She cried spontaneously but immediately developed 
gasping respirations. She was cyanotic and atonic, and was intubated 
and treated with oxygen and sodium bicarbonate; respirations im- 
proved. Apgar scores were 4 at 1 minute and 7 at 5 minutes. Chest 
roentgenogram revealed a right upper lobe infiltrate and antibiotic 
therapy was begun. Cultures were negative. A few hours after birth 
she had a generalized seizure and phenobarbital therapy was 
initiated. She was fed by nasogastric tube because of  swallowing 
difficulty. At the time of admission she had 2-3 seizures per hour. 
Laboratory studies performed prior to transport were normal, 
including complete blood counts, electrolyte analysis, ammonia and 
thyroxine levels, and a lumbar puncture. The creatine kinase (CK) 
was 130 U/L, but a skin infarction on the left thigh caused by an 
umbilical artery catheter may have caused the elevation. Computed 
tomography (CT) revealed patchy lucencies in white and gray matter. 
Physical examination revealed an extraordinarily hypotonic female 
infant (Fig 1) who appeared to be having virtually continuous 
seizures. These were characterized by myoclonic jerks, irregular 
gasping respirations, and smacking of the lips. Head turning and arm 
extension were frequent concomitants. Occasionally there were 
generalized tonic-clonic seizures. The infant had few spontaneous 
movements, but did withdraw from pain. She had a weak cry, very 
poor suck, and no grasp or Moro response. Brisk nystagmus alternated 
from horizontal to vertical. Ptosis was evident on the left. There was 
evidence of  bilateral optic atrophy. There were secondary alveolar 
ridges in the mouth and a diminished gag reflex. Deep tendon 
reflexes were absent. The temperature was 37.5 ° C., pulse I40/min, 
and respirations 40/min. The weight was 3,300 grams (below the 5th 
percentile); the length was 57 cm (60th percentile); the head cir- 
cumference was 36.5 cm (45th percentile). The necrotic area of the 
right thigh was healing with increased pigment. Roentgenographic 
survey of  the bones was normal. There were no abnormalities of the 
patellae. Renal sonogram and voiding cystourethrogram were normal. 
The hemoglobin was 9.9 gm/dl ,  hematocrit 10, leukocyte count 
6,700/mm 3 with a normal differential count, and the platelet count 
was 254,000/mm 3. The pH was 7.44, Pco2 35, and Po2 106. The 
other serum levels were: sodium 137 mEq/L, potassium 4.4 mEq/L, 
Table 1. Very long-chain saturated fatty acids in blood plasma 
Patient Control 
A B 
Hemizygote for Neonatal 
Adrenoleuko - Adrenoleuko - 
dystrophy dystrophy 
N = 2 8  
C22:0 (% total fatty acid) 0.369 0.134 1.18 ± 0.13 1.33 ± 0.13 0.69 ± 0.37 
C24:0 (% total fatty acid) 0.809 0.219 0.98 -+ 0.10 1.99 ± 0.171 1.04 ± 0.51 
C25:0 (% total fatty acid) 0.067 0.016 0.036 ± 0.07 0.17 ± 0.038 0.10 ± 0.045 
C26:0 (% total fatty acid) 0.225 0.053 0.014 ± 0.02 0.055 - 0.07 O. 14 ± 0.065 
C26:0(v.g/ml) 3.468 4.412 0.33 ± 0.18 1.62 ± 0.87 2.24 ± 0.77 
C24:0/C22:0ratio 2.192 1.634 0.84 ± 0.02 1.52 ± 0.058 t.73 + 0.35 
C26:0/C22:0ratio 0.610 0.396 0.014 ± 0.002 0.064 ± 0.005 0.29 ±0 .18  
The data for the normal controls and the hemizygotes for adrenoleukodystrophy represent the means ± standard 
deviations and were reported [9,17]. The neonatal adrenoleukodystrophy data are from an unpublished series of 
patients [20]. A and B represent two different analyses of the patient. 
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Figure 2. (A) Electron microscopic exammatlbn o f  1.0 ton tht~k plastic embedded sections o f  biopsied 
muscle stained with toluidine blue reveals nuclear enlargement and accumulations o f  mltocbondrla in the 
subsarcolemmal area. Some mitocbondna were enlarged and an occasional dumbbell-shaped 
mitochondrion was visible. (B) Paracrystalline inclufion in mitochondnon. 
bicarbonate 25 mEq/L, chloride 105 mEq/L, urea nitrogen 6 mg/dl ,  
creatinine 0.3 mg/dl ,  glucose 70 mg/dl ,  calcium 10 mg/dl ,  and total 
protein 5.4 gm/dl .  The plasma free carnitine was 86.6/,mol/L and 
the esterified fraction was 1.4/an/L. The CK was 114 U/L, aldolase 
12.3 U/L, SGPT 100 U/L, and SGOT 221 U/L. The cerebrospinal 
fluid concentration of protein was 72 mg/dl .  
The EEG revealed epileptiform abnormalities over the parieto- 
temporal area. Brainstem auditory evoked potentials were normal on 
left-sided stimulation and absent on the right, suggestive of ear 
disease on that side, but no clinical manifestation was found. Cranial 
CT revealed evidence of extensive white matter disease and some 
generalized atrophy. Electromyogram (EMG) demonstrated 
fibrillation potentials in both deltoids, right biceps, left hamstring, 
and vastus lateralis. The right ulnar motor response was of normal 
amplitude and distal latency. Nerve conduction velocities and 
repetitive nerve stimulation were normal. Muscle biopsy was 
examined by light and electron microscopy. There was histologic 
evidence of fiber size variation and many rounded, atrophic fibers. 
Accumulations of mitochondria in subsarcolemmal areas were seen on 
electron microscopy (Fig 2). Shapes and sizes varied and 
paracrystalline mitochondrial inclusions were found. These in- 
clusions, however, are nonspecific and may be seen in a variety ot 
muscle disorders. Abundant muscle glycogen was present. Small 
intramuscular nerves appeared to have axonal degeneration, con- 
sisting of axonal swelling, increased intra-axonal organelles, and 
drop-out of some axons. The myopathic changes and axonal 
degeneration observed in this patient are consistent with a diagnosis 
of  chronic neuropathy with associated myopathy. Liver biopsy 
revealed nonspecific inflammatory changes and mild periportal 
fibrosis. Prussian blue stain for iron was negative. Electron 
microscopic examination revealed normal mitochondria, an absence 
of  peroxisomes, and conspicuous bundles of intermediate filaments. 
The brain was biopsied and increased amounts of  lipofuscin pigment 
were seen in the neurons, but unfortunately white matter was not 
present in the specimen. Examination of the gray matter revealed no 
typical cellular inclusions of adrenoleukodystrophy. 
Effort was made to control the seizures but despite continued 
therapy with clonazepam, phenobarbital, and phenytoin and 
documentation of excellent therapeutic levels in the blood, little 
changed in the pattern of seizures. An intercurrent urinary tract 
infection was responsive to antibiotic treatment, and renal sonogram 
and voiding cystourethrogram were normal. She developed a left 
otitis media and right upper lobe pneumonia which also responded to 
antibiotic therapy. 
A prolonged fast resulted in hypoglycemia. A blood glucose of 38 
mg/dl  at 16 hours was observed. The concentration of glucose rose to 
90 mg/dl after glucagon (0.5 mg, IM). These observations indicated 
that gluconeogenesis was normal but adrenal function might have 
been impaired. Blood was tested for long-chain, saturated fatty acids. 
The blood concentration of cortisol was < 2.5 p,g/dl, but rose to 85.2 
/*g/dl after 6, twice-a-day injections of ACTH. Dietary attempts to 
limit the intake of long-chain fatty acids were not successful because 
of the development of diarrhea. Similarly, carnitine therapy was not 
effective. At 4 months of age the patient returned to Saudi Arabia 
where she died shortly thereafter. 
Methods 
Cell culture of fibroblasts was obtained following skin biopsy. Cells 
were grown at 37 °C. in Eagle's minimum essential medium con- 
taining fetal calf serum. Harvesting of the cells, extraction of lipids 
from fibroblasts and plasma, and purification and assay of fatty acid 
methyl esters were performed as described previously [3,4] using a 
system of capillary gas-liquid chromatography for the quantitation of 
very long-chain fatty acids. Dihydroxyacetone phosphate acyltrans- 
ferase was assayed in whole fibroblast homogenates by measuring the 
amount of labeled lipid formed from 32P-dihydroxyacetone 
phosphate as described previously [ 11,12 ]. 
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Table 2. Very long-chain saturated fatty adds in cultured fibroblasts 
Patient Control 
Hemizygous for Neonatal 
Adrenoleukodys - Adrenoleukodys - 
trophy trophy 
N =25 
C22:0 (p.g/mgprotein) 0.270 0.99 ± 0.44 0.59 ± 0.13 0.49 _+ 0.22 
C26.0 0~g/mgprorein) 0.474 0.066 ± 0.35 0.45 ± 0.05 0.39 -+ 0.16 
C26:1 0@ /mg protein) 0.73 0.079 ± 0.066 0.21 ± 0.08 0.68 _+ 0.47 
C26:0 / C22:0rario 1.756 0.064 ± 0.019 0.76 ± 0.09 0.88 ± 0.41 
The mean values for neonatal adrenoleukodystrophy are from an unpublished series [20]. Some 
of the control and X-linked data have been reported [3], while others represent unpublished 
data [20]. 
Re~al ts  Table 5. 
The concentrations of very long-chain saturated fatty 
acids in the plasma of the patient are shown in Table 1. 
The values were markedly elevated. The concentrations 
of C26:0 were considerably greater than those of 
children hemizygous for adrenoleukodystophy [9] and 
10 times greater than the control mean. In a series of 
patients with neonatal adrenoleukodystrophy the mean 
was 2.24 _ 0.77 [4,20]. The ratios of C24:0 to C22:0 
and C26:0 to C22:0 were both markedly elevated. 
The data for cultured fibroblasts are presented in 
Table 2. The concentration of C22:0 acid was relatively 
low while that of C26:0 was 6.5 times the control mean. 
The ratio of C26:0 to C22:0 not only exceeded the 
control ratio, but also was more than twice the value 
obtained in fibroblasts from adrenoleukodystrophy 
hemizygotes. In a series of patients with neonatal 
adrenoleukodystrophy the mean concentration of 
C26:0 in fibroblasts was 0.39 ~g/mg protein _+ 0.16, a 
level similar to that of 0.474 ~g/mg protein, obtained 
in the patient. The concentration of C26:1 in the 
patient's fibroblasts was 0.73 ~g/mg protein. This 
value is similar to those found in neonatal 
adrenoleukodystrophy (mean value of 0.68), and in the 
Zellweger syndrome [4], in which the mean value was 
1.33. The concentration of pipecolic acid in the urine is 
listed in Table 3. (Plasma was no longer available). The 
markedly elevated concentration was 1.94 fanol/mg Patient 
crearinine; a patient with hyperpipecolic acidemia had 
a value of 1.92 ~a'nol/mg creatinine, and also had a 
distinct elevation of the plasma level ofpipecolic acid to 
74.6 nmol/ml; the level of the control group was 1-2 
nmol/ml. Healthy individuals have very low levels of 
pipecolic acid in body fluids [13]. 
The oxidation of 14C-labeled fatty acids was studied Control 
in fibroblasts as described by Singh et al. [14] (Table 4). 
Urinary coaceatmtioa of ~ ¢  acid 
l'tpeco~ Acid 
mno~/m] ' ~ t a t S ~ , , i , , ~  
Patient 155.2 1.94 
Patient with 
pipecolic acidemia 230.8 1.92 
The oxidation of palmitic acid was normal. The 
oxidation of lignoceric acid (C24) was 39% of the 
control. The use of the ratio of C16/C24 reduces 
variation in different sets of fibmblasts assayed. The 
value in the patient was 2.8 times control. 
Table 5 lists data on the activity of dihydmxyacetone 
phosphate acyltransferase, the fwst enzyme of the 
metabolic pathway for the biosynthesis of the glycerol- 
Table 4. (t4C) CO2 release from (1.v~) p-lm;6c attd (l.tq2) 
U~oc~t~ ada in ~m~..~u~ o~miutd ~i~ ~ It4] 
CI6 C24 C161C24 
cpm/ms pam~i. 
14200 213 67 
Zellweger 10700 129 83 
X-linked adrenoleuko- 
dystrophy 
11000 204 54 
13000 545 24 
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Table 5. Activity of dihydroxyacetone phosphate acyltransferase 
Activity 
~mol / rain /mg protein 
Patient 0.06 
Zellweger 0.02 
Neonatal adrenoleukodystrophy 0.03 -0.06 
Controls 0.23 -0.35 
ether lipids and plasmalogen. Cultured fibroblasts 
derived from the patient approximated 20 % of control 
values. Similar values were observed in the Zellweger 
and neonatal adrenoleukodystrophy syndromes 
[11,15]. 
Discussion 
The clinical phenotype of this patient was typical, or 
possibly more severe than that described in neonatal 
adrenoleukodystrophy [1,5-8]. Extreme hypotonia, 
present at birth, necessitated endotracheal intubation, 
resuscitation in the delivery room, and feeding by 
nasogastric tube. Deep tendon reflexes could not be 
obtained. The intractable seizure disorder began within 
hours of birth. Myoclonic and generalized tonic-clonic 
seizures were virtually continuous. During the few 
months of her life she had no psychomotor develop- 
ment. In addition she had none of  the dysmorphic 
features seen in the Zellweger syndrome. 
The elevated plasma concentrations of long-chain 
fatty acids indicated that this patient had a peroxisomal 
disorder. These subcellular organdies contain the 
system for the hepatic oxidation of very long-chain fatty 
acids [16]. Accumulations of very long-chain fatty acids 
in the neonatal period have been found consistently in 
neonatal adrenoleukodystrophy and Zellweger syn- 
dromes [1,2,4,17]. Elevated concentrations of very 
long-chain fatty acids also have been found in two of 
three patients with pipecolic acidemia; normal con- 
centrations were found in the third [4]. 
The biochemical characteristics of this patient were 
documented thoroughly. The ratio of C26/C22 in 
fibroblasts and the concentrations of C26:1 were 
elevated. The elevated level of pipecolic acid in the 
urine was consistent with previous observations of  
pipecolic acidemia and Zellweger syndrome. The data 
on the release of 14CO2 from x4C-labeled palmitic and 
lignoceric acids revealed defective oxidation of very 
long-chain fatty acids. Similar results on fatty acid 
oxidation were obtained in adrenoleukodystrophy, 
neonatal adrenoleukodystrophy, and Zellweger syn- 
drome [11,15,17-21]. The peroxisomal enzyme, 
dihydroxyacetone phosphate acyltransferase, which 
catalyzes the first step in plasmalogen synthesis, was 
reported to be defective in Zellweger syndrome [22-24]. 
It is also defective in neonatal adrenoleukodystrophy, 
but is normal in X-linked adrenoleukodystrophy. This 
peroxisomal activity also was markedly defective in our 
patient. 
Hepatic peroxisomes were not identifiable on 
electron microscopy in our patient. In Zellweger 
syndrome, peroxisomes are absent or very small and 
irregularly shaped [24]. The situation is not clear in 
neonatal adrenoleukodystrophy, but absence of  hepatic 
peroxisomes has been reported in this condition [25]. In 
contrast, hepatic peroxisomes are present in hyper- 
pipecolic acidemia which suggests that this patient did 
not have the disease [26]; however, the absence of a 
finding is not definitive proof. Until the molecular 
defects in these conditions have been better defined, 
clinical phenotype must be used to distinguish among 
these three disorders of young infants in which very 
long-chain fatty acids accumulate. 
Other laboratory findings in our patient also were 
only suggestive of the diagnosis. Hepatic fibrosis is an 
integral component of  neonatal adrenoleukodystrophy. 
Elevation of serum transaminases and other enzymes [1] 
in an infant with extreme hypotonia and convulsions 
could serve as an alerting signal to the diagnosis. 
Mitochondrial morphologic abnormalities in the liver 
are seen in Zellweger syndrome [18] but our patient's 
mitochondria in the liver were normal in shape. 
In our patient, the development of hypoglycemia 
during fasting in the presence of a normal response to 
glucagon suggested adrenal hypofunction; however, 
the response to ACTH was normal. Signs of adrenal 
insufficiency are usually absent in neonatal adreno- 
leukodystrophy, and a normal cortisol response to 
ACTH was observed in one patient in whom the 
diagnosis was documented at autopsy [1]. The term 
neonatal adrenoleukodystrophy may be a misnomer. 
Although they are involved histologically, the adrenals 
are much less important than other organs in the 
phenotype. 
CT scan, even in early infancy, revealed extensive 
disease of the white matter in our patient. Although " 
this was reported in neonatal adrenoleukodystrophy 
[7], CT scan also was reported to be normal or to show 
minimal abnormalities [1]. The brainstem auditory 
evoked potentials in our patient revealed no response 
on the right side, while the response on the left was 
normal. She had had no infections prior to the test and 
there was no evidence of auditory disease. Asymmetric 
abnormality in the brainstem auditory evoked response 
has been reported in adrenoleukodystrophy [27]. Also, 
patients with neonatal adrenoleukodystrophy have 
inclusions in macrophages of the white matter. The 
absence of these characteristic inclusions in a small 
sample of biopsied gray matter does not exclude the 
diagnosis. 
Muscle changes in the patient were of interest and 
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have not been described previously in either neonatal 
adrenoleukodystrophy or in Zellweger syndrome. The 
mitochondrial inclusions, evidence of myopathy, and 
neurogenic muscular atrophy, are consistent with the 
profound hypotonia displayed by the patient. Con- 
versely, hypotonia is characteristic of neonatal 
adrenoleukodystrophy and may be a uniform 
characteristic of this disorder. Mitochondrial ab- 
normalities in the liver were reported in some but not 
all patients with the Zellweger syndrome [28,29] but 
information on muscle is not available. 
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